Official Press Releases
CureMatch receives a new investment by Tech Entrepreneur Phil Trubey on the heels of San Diego Venture Group’s selection of CureMatch as a venture-ready company. SAN DIEGO, CA – June 14, 2017 –CureMatch, a digital health company that guides oncologists in the selection of advanced cancer therapies, today announced that Phil Trubey had joined a […]
Many of these precision oncology findings have been incorporated into the intelligence of the CureMatch decision support platform. CHICAGO, IL – June 2, 2017 – UCSD oncologist and CureMatch Co-Founder Dr. Razelle Kurzrock and colleagues are presenting ground-breaking cancer discoveries on a variety of topics related to personalized cancer therapy at the American Society of Clinical Oncology […]
SAN DIEGO, CA – May 20, 2017 –CureMatch™ today was selected by the San Diego Venture Group as one of its 2017 Cool Companies. SDVG’s list of Cool Companies are those determined to be “venture-ready” and among the “fastest-growing, most exciting startups in Southern California.” The Fastest-Growing, Most Exciting Startups in San Diego A total of 37 […]
CureMatch makes it affordable for all to get personalized cancer treatment, and offers the decision support system service for free for children with cancer SAN DIEGO, CA – May 25, 2017 –CureMatch™ today announced the pricing for its Personalized Combination Therapy™ report. The report guides oncologists in the selection of cancer treatment options that are […]
Study suggests that genomic profiling may help identify risk for hyper-progression after immunotherapy SAN DIEGO, CA – May 4, 2017 – UCSD oncologist and CureMatch Co-Founder Dr. Razelle Kurzrock and colleagues have published a study in the journal Clinical Cancer Research investigating “hyper-progressors.” Hyper-progressors are patients who unexpectedly fail immunotherapy treatment within 2 months, while also experiencing rapid […]
